Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Communiqué from Genovis AB (publ) Annual General Meeting May 17, 2018

The Annual General Meeting adopted the following resolutions:  · The balance sheet and income statement were adopted. · The Board and the Chief Executive Officer were discharged from liability.  · The Board shall consist until the next AGM of six ordinary members without deputies.  · Ordinary members Kenth Petersson, Mikael Lönn, Lena Mårtensson Wernrud and Mårten Winge were re-elected.Lena Söderström och Peter Hein was elected new Board members.Mårten Winge was elected Chairperson of the Board.  · Remuneration will be paid to the Board of Directors in the amount of

REPORT FROM BJÖRN BORG’S ANNUAL GENERAL MEETING

The Annual General Meeting of Björn Borg AB was held at 5.30 p.m. on 17 May 2018 at the company’s offices in Stockholm.The Annual General Meeting adopted the income statement and balance sheet, the consolidated income statement and the consolidated balance sheet for the year 2017. The Annual General Meeting resolved that no dividend be paid to the shareholders for the year 2017. Instead of a dividend, the Annual General Meeting resolved on a share redemption program as set out below.   Directors The Annual General Meeting resolved to re-elect the Directors Christel Kinning, Fredrik

Bulletin from the Annual General Meeting in Oncopeptides AB (Publ)

Stockholm, Sweden – 17 May 2018 – Oncopeptides AB (publ)’s (ONCO) Annual General Meeting 2018 was held today, at Tändstickspalatset in Stockholm. At the Annual General Meeting, the following principal resolutions were passed.· The presented annual report was adopted and the members of the Board of Directors and the CEO were discharged from liability in respect of the financial year 2017. · It was resolved to carry forward the loss for the year in accordance with the Board of Directors’ proposal. · The proposed remunerations to the Board of Directors, its committees and the Company’s

BJÖRN BORG AB INTERIM REPORT JANUARY – MARCH 2018

ONLINE SALES GROW 1 JANUARY – 31 MARCH, 2018 · The Group’s net sales fell 8.9 percent to SEK 169.2 million (185.7). Excluding currency effects sales fell 10.6 percent. · The gross profit margin was 57.1 percent (48.9). · Operating profit amounted to SEK 15.1 million (6.7). · Profit after tax amounted to SEK 14.9 million (5.0). · Earnings per share before and after dilution amounted to SEK 0.60 (0.18). QUOTE FROM THE CEO “The quarter’s biggest victory is that we ranked number 4 in our last consumer survey in Sweden among sports apparel brands, where the

Fiskars Corporation: Acquisition of Own Shares 17.05.2018

Fiskars Corporation NOTIFICATION   17.05.2018 at 18:30 EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.05.2018 Date 17.05.2018Exchange transaction BuyShare class FSKRSAmount 1500Average price/share 19.7672 EURHighest price/share 19.9600 EURLowest price/share 19.6800 EURTotal price 29,650.80 EUR The shares held by Fiskars Corporation on 17.05.2018: FSKRS  181,199 On behalf of Fiskars CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti Salakka    Janne

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 17.05.2018

United Bankers Corporation NOTIFICATION 17.05.2018 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 17.05.2018 Date 17.05.2018Exchange transaction BuyShare class UNIAVAmount 100Average price/share 7.1000 EURHighest price/share 7.1000 EURLowest price/share 7.1000 EURTotal price 710.00 EUR The shares held by United Bankers Corporation on 17.05.2018: UNIAV 37,660 On behalf of United Bankers Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

Triton to sell Aventics to Emerson

Laatzen (Germany), 17 May 2018 – Triton has initiated the next step to ensure a prosperous and sustainable future for Aventics by announcing its intention to sell the company to Emerson. There has been an agreement on terms with Emerson and the regulatory approval process is now underway. Emerson (NYSE: EMR), headquartered in St. Louis, Missouri (USA), is a global technology and engineering company providing innovative solutions for customers in industrial, commercial, and residential markets. The Emerson Automation Solutions business helps process, hybrid, and discrete manufacturers

Distribution and listing of Epiroc AB

Stockholm, Sweden, May 17, 2018: The Annual General Meeting of Atlas Copco AB decided on April 24 to distribute all shares of Epiroc AB to the shareholders of Atlas Copco AB. The Board of Directors was authorized to determine the record date for the distribution. The record date has now been set to June 14, 2018, and the first day of trading in Epiroc AB is expected to be June 18, 2018.Nasdaq Stockholm’s Listing Committee has resolved to admit Epiroc’s shares of series A and shares of series B to trading on Nasdaq Stockholm subject to customary conditions, such as the Swedish Financial

Report from the Annual General Meeting in Nexam Chemical Holding (publ)

Today, Thursday May 17, 2018, an Annual General Meeting (the “AGM”) was held in Nexam Chemical Holding AB (publ). At the AGM, 7,943,439 shares were represented, which corresponds to approximately 12 % of the total number of shares. A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes.Adoption of accounts and distribution of the company’s results   The AGM resolved to adopt the presented profit and loss statement and balance sheet, as well as the consolidated profit and loss statement and consolidated balance sheet. The AGM

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release May 17, 2018, at 5:45 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on May 17, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, BlackRock, Inc.'s indirect holding in Nokian Tyres shares fell below level of 5% as well as the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as result of share transactions concluded on May 16, 2018. Total positions of BlackRock, Inc. and its

Annual General Meeting in Munters Group AB

At the annual general meeting in Munters Group AB held today the following main resolutions were taken.Adoption of the income statement and the balance sheet for the company and the group The meeting resolved on the adoption of the presented income statement and the balance sheet and the consolidated income statement and consolidated balance sheet as per 31 December 2017. Dividend In accordance with the Board’s proposal, the annual general meeting resolved to declare a dividend of SEK 0.30 per share. Monday 21 May 2018 was determined as record date for the payment of dividend.

Report from Balco Group AB’s Annual General Meeting 2018

The shareholders of Balco Group AB ("Balco" or "the Company") gathered today on Thursday 17 May 2018 in Växjö, Sweden, for the Annual General Meeting.The Annual General Meeting of Balco approved the profit and loss statement and the balance sheet and the consolidated profit and loss statement and consolidated balance sheet and granted the members of the Board of Directors and the CEO discharge from liability for the financial year 2017. The Annual General Meeting resolved to allocate the Company’s profits in accordance with the proposal made by the Board of Directors in the annual report.

Appointment in Componenta’s Corporate Executive Team

Componenta Corporation Stock Exchange Release 17 May 2018 at 17.00 Mervi Immonen has been appointed Group General Counsel and as a member of the Corporate Executive Team of Componenta Corporation as of 17 May 2018. She has worked as company’s Legal Counsel since 2017 and several years in different legal and managerial positions before joining Componenta. Mervi Immonen reports to CEO and President Harri Suutari. As of 17 May 2018, Componenta’s Corporate Executive Team consist of CEO Harri Suutari, Group General Counsel Mervi Immonen, CFO Marko Karppinen and COO Pasi Mäkinen.

Amgen, Sandoz, ThermoFisher Scientific and IQVIA join Monocl’s customer portfolio

· Monocl welcomes a range of global leading pharmaceutical companies, scientific instrument manufacturers and CROs to its rapidly growing customer base. · The company closed its largest deal to date in Q1 2018 with a non-disclosed top 5 Big Pharma. · To further fuel its rapid growth, Monocl will initiate a Series A funding round during Q2 2018. Björn Carlsson, CEO of Monocl, sums it up: “The first quarter of 2018 was our strongest to date. This is very exciting since we beat our previous all-time high from the final quarter of 2017. The fact that our performance is exceeding our

Healthcare IT business Trialbee pursues strategic expansion through new talent and investment

Swedish clinical trial technology firm Trialbee announces the appointment of several new senior leadership positions and new investments. This injection of talent and funding will underpin Trialbee’s plans for corporate growth and expansion into the US market.Trialbee mobilizes and prepares for strategic expansion through the addition of new investments. Trialbee is a Swedish clinical trial technology company providing smart patient matching and engagement services to accelerate drug development for pharmaceutical companies and contract research organizations (CROs) around the world.

Summer news from Rapunzel of Sweden

Rapunzel of Sweden launches three news in limited edition for summer. A new anti-static leave-in spray that shreds and moisturises hair, a headband and a real-hair scrunchie for the ultimate "messy bun". The news is perfect for warm and lazy days at the beach, they can be styled both together or separately.Hair Scrunchie Rapunzels Hair Scrunchie in real hair gives you a trendy hairstyle in no time! With Hair Scrunchie you can quickly create a stylish look. The hair scrunchie has an genuine hair around the hairband and you can easily create a your favorite hair style and at the same

Vator Securities acted as Sole Bookrunner and Advisor in connection with Ascelia Pharmas Pre-IPO share issue

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 60 million.Ascelia Pharma is a Swedish-based specialty oncology drug development company with a late stage pipeline of products with potential to significantly improve survival in cancer patients. The lead asset Mangoral® is a novel MR imaging (MRI) drug, which is being developed for detection of liver metastases in patients with severely impaired kidney function who are at risk of serious side effects if given any of the current imaging drugs on the market. Today, these patients have no

Invitation to presentation of Sectra’s year-end report on May 29

Linköping, Sweden – May 17, 2018 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will publish its year-end report for the period May 2017 to April 2018 on May 29, 2018. Sectra invites analysts, investors, and the media to attend a presentation in conjunction with the publication of the report.Publication of year-end report: 8:00 a.m. May 29, 2018 Presentation: 12:00 noon. May 29, 2018 Place: Operaterrassen in Stockholm, Sweden To attend the conference, please submit a notification via: http://www.

Voith Moves to Basware Invoice Receiving Service

Espoo, Finland, 17 May 2018 – Basware, the global leader in networked source-to-pay solutions, e-invoicing and innovative financing services, has signed a new deal with Voith Global Business Services EMEA GmbH. Voith  is a new customer to Basware. “Voith was originally looking for an OCR-based solution to digitalize their paper-based vendor invoices. But our versatile approach to start with scanning/OCR and then activate suppliers to move to electronic invoicing convinced them that Basware’s way of doing things offers better business case and is more

#18-846 Listing of instrument issued by UBS AG

As from May 21, 2018, 1 instrument issued by UBS AG will be listed on NDX Miscellaneous Investment Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: UBS AG Agent: Exceed For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart,

#18-845 Listing of instruments issued by SG Issuer

As from May 21, 2018, 2 instruments issued by SG Issuer will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: SG Issuer Agent: Exceed For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the

ExpreS2ion’s core platform patent allowed in Canada

ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announce that the Company’s patent application “Improved Protein Expression System”, that covers the entire ExpreS2 platform, has been allowed in Canada and will be granted with expiry June 12, 2029.“With the patent allowance in Canada, ExpreS2ion has now successfully obtained patent protection of its ExpreS2 platform in all major markets of interest. Thereby the major initial goal for our ExpreS2 platform patent portfolio, which is fundamental to our business, has been reached," says Dr. Steen

There are no items matching the current filter
There are no more items matching the current filter
Back to top